ACC CardiaCast – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

ACC CardiaCast

American College of Cardiology

Health & Fitness

Frequency: 1 episode/9d. Total Eps: 99

This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts.

Site

RSS

Apple

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

🇫🇷 France - medicine
30/04/2026
#100
🇫🇷 France - medicine
29/04/2026
#72
🇫🇷 France - medicine
20/03/2026
#96
🇫🇷 France - medicine
19/03/2026
#75
🇫🇷 France - medicine
08/12/2025
#84
🇫🇷 France - medicine
07/12/2025
#48
🇫🇷 France - medicine
25/11/2025
#85
🇫🇷 France - medicine
24/11/2025
#72
🇬🇧 Great Britain - medicine
14/11/2025
#90
🇨🇦 Canada - medicine
02/08/2025
#93

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://itunes.apple.com/us/podcast/acc-cardiacast/id1376040940
20 shares

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 53%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

ACC CardiaCast: Pulse Check: What’s New in Lipid Management for the Pharmacist CV Team Professional?

Monday, October 28, 2024 • Duration 20:55

Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based solutions to the everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific Pharmacist focus. In this episode, Andrea Price, MS, AACC hosts Tomasz Jurga, PharmD, BCPS, BCACP, BCCP, HF-Cert, AACC; Lydia Tran, PharmD, BCPS and Bruce Warden, PharmD, BCPS, FNLA, FASPC to discuss the role of the pharmacists of the care team for lipid management.

Subscribe to CardiaCast

Read moreCollapse

Pulse Check: What’s New in Hypertension Management for the Pharmacist CV Team Professional?

Monday, October 21, 2024 • Duration 12:44

Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based solutions to the everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific Pharmacist focus. In this episode, Andrea Price, MS, AACC hosts Lydia Tran, PharmD, BCPS and Sushma Dey, PharmD, BCACP to discuss the role of the pharmacists on the care team for hypertension management.

Subscribe to CardiaCast

Read moreCollapse

Pulse Check: Introduction to PAD

Monday, September 9, 2024 • Duration 13:19

PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This series, published during Peripheral Artery Disease (PAD) Awareness Month, is in collaboration with the ACC’s Vascular Disease Section. In this episode, Andrea Price, MS, AACC hosts Hussein Abu Daya MD, FACC, Brian Rose, PA-C, MPH, AACC and Bailey Estes MSN, AGNP-C, to begin the PAD series with an introductory overview.

Read moreCollapse

ACC CardiaCast: Courtside with the Chair: Shared Decision-Making with Athletes: A Discussion of ‘How To’? Part 2

Friday, August 16, 2024 • Duration 22:25

“Courtside with the Chair” is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this “Part 2” episode, Dr. Jonathan Kim continues the conversation with Drs. Michael Ackerman, Rachel Lampert, and Matthew Martinez of the “how to” and approach to shared decision-making in the context of sports participation for athletes with heart disease.

Suggested Materials: (You can include formal references external to ACC.org here. Please list numerically as formal citations. Example: Cannon JA, Moffitt P, Perez-Moreno AC, et al. Cognitive impairment and heart failure: systematic review and meta-analysis. J Card Fail 2017;23:464-75).

Subscribe to CardiaCast | Claim CME Credit

Read moreCollapse

Hope on the Horizon: Emerging Therapies for Elevated Lp(a)

Monday, August 12, 2024 • Duration 19:19

In this episode, Drs. Erin Michos and Steven Nissen discuss newly emerging therapies for elevated Lp(a) management and forthcoming developments in research. Drs. Michos and Nissen highlight the key differences between therapies in late trial stages and discuss upcoming cardiovascular outcome trials.

This CardiaCast episode is part of an ACC course titled Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap. Educational grant support is provided by Novartis. To visit the Online Course page for the Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap Grant, click here!

Suggested Materials:

Reyes-Soffer G, Yeang C, Michos ED, Boatwright W, Ballantyne CM. High lipoprotein(a): actionable strategies for risk assessment and mitigation. Am J Prev Cardiol. 2024;18:100651.

Tsimikas S, Fazio S, Ferdinand KC, et al. NHLBI Working Group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis. J Am Coll Cardiol 2018;71:177-92.

Reyes-Soffer G, Ginsberg HN, Berglund L, et al; on behalf of the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; and Council on Peripheral Vascular Disease. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association. ArteriosclerThromband Vasc Biol 2022;42:e48-e60.

Koschinsky ML, Bajaj A, Boffa MB, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol 2024;18:e308-e319.

Subscribe to CardiaCast | More information on Elevating Lp(a) HERE

Courtside with the Chair: Shared Decision-Making with Athletes: A Discussion of “How To”? Part 1

Friday, August 9, 2024 • Duration 22:16

“Courtside with the Chair” is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Michael Ackerman, Rachel Lampert, and Matthew Martinez to discuss the “why” and “how to” related to shared decision-making in the context of sports participation for athletes with heart disease.

Subscribe to CardiaCast | Claim CME Credit

Read moreCollapse

PulseCheck: UPDATE: Shared Decision Making

Monday, August 5, 2024 • Duration 16:38

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This episode is an update to the March 2024 PulseCheck: Shared Decision Making podcast in which host Andrea Price MS, AACC brings together Liz Perpetua ARNP, ACNP-BC, DNP, FACC, Martha Gulati MD, MS, FACC, and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease. Dr. Perpetua, the chair and lead author of JACC Advances Expert Panel Perspective: Shared Decision-Making in Multidisciplinary Team-Based Cardiovascular Care, offers insights from the July 2024 publication.

Subscribe on iTunes | Subscribe on Google Play |

Read moreCollapse

ACC CardiaCast: Elevated Lp(a): Actionable Strategies for Risk Assessment and Mitigation

Monday, July 29, 2024 • Duration 19:28

In this episode, Drs. Erin Michos and Gissette Reyes-Soffer discuss how clinicians can manage elevated Lp(a) by treating all modifiable factors in patients. The global risk assessment of patients and what can be done now to navigate and mitigate risk is also addressed.

Suggested Materials:

Reyes-Soffer G, Yeang C, Michos ED, Boatwright W, Ballantyne CM. High lipoprotein(a): actionable strategies for risk assessment and mitigation. Am J Prev Cardiol 2024;18:100651.

Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, et al. NHLBI Working Group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis. J Am Coll Cardiol 2018;71:177-92.

Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, et al; on behalf of the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; and Council on Peripheral Vascular Disease. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol 2022;42:e48-e60.

Koschinsky ML, Bajaj A, Boffa MB, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol 2024;Mar 29:[ePub ahead of print].

Subscribe to CardiaCast | More information on Elevating Lp(a) HERE

The What, Who, When and Why of Lipoprotein(a)

Monday, July 15, 2024 • Duration 18:23

In this episode, Drs. Erin Michos and Christie Ballantyne examine the importance of testing and identifying lipoprotein(a) ( Lp[a]) levels in patients, research highlighting trends in populations at risk, and the genetic factors involved in assessment. The significance associated with various levels of Lp(a) in measurement and how testing plays a role in management is also discussed.

Read moreCollapse

ACC CardiaCast: VA ECMO: A Review of Randomized Clinical Trials

Friday, July 12, 2024 • Duration 27:22

In this episode, Drs. Maya Guglin, Nikhil Narang, Dustin Hillerson, Anju Bhardwaj, and Megan Pelter will delve into recently published randomized controlled clinical trials on venoarterial extracorporeal membrane oxygenation (VA-ECMO). They will cover trials on cardiogenic shock, including the ECMO-CS multicenter randomized trial, and discuss findings from the EVOLVE-ECMO trial on left ventricular venting.

Read moreCollapse

ACC CardiaCast – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

ACC CardiaCast – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

Other29

Apple Podcast1

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Other29

Apple Podcast1

Related Shows Based on Content Similarities